Pfizer Statistics
Share Statistics
Pfizer has 5.67B shares outstanding. The number of shares has increased by 0.36% in one year.
| Shares Outstanding | 5.67B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 5.67B |
| Failed to Deliver (FTD) Shares | 122.80K |
| FTD / Avg. Volume | 0.29% |
Short Selling Information
The latest short interest is 61.87M, so 1.09% of the outstanding shares have been sold short.
| Short Interest | 61.87M |
| Short % of Shares Out | 1.09% |
| Short % of Float | 1.09% |
| Short Ratio (days to cover) | 1.83 |
Valuation Ratios
The PE ratio is 76.67 and the forward PE ratio is 8.94. Pfizer 's PEG ratio is 0.13.
| PE Ratio | 76.67 |
| Forward PE | 8.94 |
| PS Ratio | 2.78 |
| Forward PS | 2.4 |
| PB Ratio | 1.83 |
| P/FCF Ratio | 33.9 |
| PEG Ratio | 0.13 |
Enterprise Valuation
Pfizer Inc. has an Enterprise Value (EV) of 234.65B.
| EV / Earnings | 110.74 |
| EV / Sales | 4.01 |
| EV / EBITDA | 24.55 |
| EV / EBIT | 69.86 |
| EV / FCF | 48.96 |
Financial Position
The company has a current ratio of 0.91, with a Debt / Equity ratio of 0.81.
| Current Ratio | 0.91 |
| Quick Ratio | 0.69 |
| Debt / Equity | 0.81 |
| Total Debt / Capitalization | 44.68 |
| Cash Flow / Debt | 0.12 |
| Interest Coverage | 1.52 |
Financial Efficiency
Return on equity (ROE) is 0.02% and return on capital (ROIC) is 4.31%.
| Return on Equity (ROE) | 0.02% |
| Return on Assets (ROA) | 0.01% |
| Return on Capital (ROIC) | 4.31% |
| Revenue Per Employee | 664.73K |
| Profits Per Employee | 24.08K |
| Employee Count | 88.00K |
| Asset Turnover | 0.26 |
| Inventory Turnover | 2.91 |
Taxes
| Income Tax | -1.11B |
| Effective Tax Rate | -1.05 |
Stock Price Statistics
The stock price has increased by -6.68% in the last 52 weeks. The beta is 0.61, so Pfizer 's price volatility has been higher than the market average.
| Beta | 0.61 |
| 52-Week Price Change | -6.68% |
| 50-Day Moving Average | 26.79 |
| 200-Day Moving Average | 27.96 |
| Relative Strength Index (RSI) | 56.32 |
| Average Volume (20 Days) | 42.64M |
Income Statement
In the last 12 months, Pfizer had revenue of 58.50B and earned 2.12B in profits. Earnings per share was 0.38.
| Revenue | 58.50B |
| Gross Profit | 28.81B |
| Operating Income | 3.36B |
| Net Income | 2.12B |
| EBITDA | 9.56B |
| EBIT | 3.36B |
| Earnings Per Share (EPS) | 0.38 |
Balance Sheet
The company has 2.85B in cash and 70.84B in debt, giving a net cash position of -67.99B.
| Cash & Cash Equivalents | 2.85B |
| Total Debt | 70.84B |
| Net Cash | -67.99B |
| Retained Earnings | 118.35B |
| Total Assets | 219.48B |
| Working Capital | 12.00M |
Cash Flow
In the last 12 months, operating cash flow was 8.70B and capital expenditures -3.91B, giving a free cash flow of 4.79B.
| Operating Cash Flow | 8.70B |
| Capital Expenditures | -3.91B |
| Free Cash Flow | 4.79B |
| FCF Per Share | 0.85 |
Margins
Gross margin is 49.25%, with operating and profit margins of 5.74% and 3.62%.
| Gross Margin | 49.25% |
| Operating Margin | 5.74% |
| Pretax Margin | 1.81% |
| Profit Margin | 3.62% |
| EBITDA Margin | 16.34% |
| EBIT Margin | 5.74% |
| FCF Margin | 8.19% |
Dividends & Yields
PFE pays an annual dividend of $1.72, which amounts to a dividend yield of 6.44%.
| Dividend Per Share | $1.72 |
| Dividend Yield | 6.44% |
| Dividend Growth (YoY) | 4.88% |
| Payout Ratio | 229.33% |
| Earnings Yield | 1.42% |
| FCF Yield | 3.17% |
Analyst Forecast
The average price target for PFE is $32, which is 19.9% higher than the current price. The consensus rating is "Hold".
| Price Target | $32 |
| Price Target Difference | 19.9% |
| Analyst Consensus | Hold |
| Analyst Count | 14 |
Stock Splits
The last stock split was on Nov 17, 2020. It was a forward split with a ratio of 527:500.
| Last Split Date | Nov 17, 2020 |
| Split Type | forward |
| Split Ratio | 527:500 |
Scores
| Altman Z-Score | 1.86 |
| Piotroski F-Score | 6 |